Clinical trials
Withdrawn Phase 1 Diabetes Mellitus trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Missouri-Columbia | 2 |
| Baylor Research Institute | 1 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 1 |
| Columbia University | 1 |
| Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. | 1 |
| University of Oklahoma | 1 |
| University of Wisconsin, Madison | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 8 |
| Diabetes Mellitus, Type 1 | 3 |
| Obesity | 2 |
| Atherosclerosis | 1 |
| Bone Diseases, Metabolic | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Hyperglycemia | 1 |
| Hyperinsulinism | 1 |
| Hypoglycemia | 1 |
| Inflammation | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.